SILICON LABORATORIES INC.
Financial highlights
| Metric | FY 01/03/26 | FY 12/28/24 | FY 12/30/23 | FY 12/31/22 | FY 01/01/22 |
|---|---|---|---|---|---|
| Income Statement | |||||
| Revenue | $784.8M | $584.4M | $782.3M | $1.0B | $720.9M |
| Cost of revenue | $327.8M | $272.2M | $321.7M | $381.5M | $295.5M |
| Gross profit | $457.0M | $312.2M | $460.6M | $642.6M | $425.4M |
| Selling, general & administrative | $174.3M | $145.5M | $147.0M | $191.0M | $185.0M |
| Research and development | $353.2M | $332.2M | $337.7M | $332.3M | $273.2M |
| Operating expenses | $527.5M | $477.7M | $484.7M | $523.3M | $458.2M |
| Operating income | -$70.5M | -$165.5M | -$24.2M | $119.3M | -$32.8M |
| Interest expense | $975,000 | $1.3M | $5.6M | $6.7M | $31.0M |
| Pretax income | -$57.9M | -$154.8M | -$10.5M | $126.5M | -$58.2M |
| Income tax expense | $7.0M | $36.2M | $7.9M | $38.5M | $13.4M |
| Net income | -$64.9M | -$191.0M | -$34.5M | $91.4M | $2.1B |
| Balance Sheet | |||||
| Cash and equivalents | $364.2M | $281.6M | $227.5M | $499.9M | $1.1B |
| Current assets | $674.0M | $602.0M | $737.9M | $1.5B | $2.2B |
| Total assets | $1.3B | $1.2B | $1.4B | $2.2B | $3.0B |
| Current liabilities | $143.8M | $97.9M | $163.6M | $185.8M | $668.8M |
| Total liabilities | $174.9M | $142.7M | $234.4M | $764.4M | $745.9M |
| Stockholders' equity | $1.1B | $1.1B | $1.2B | $1.4B | $2.2B |
| Cash Flow Statement | |||||
| Cash from operations | $95.7M | -$13.9M | -$30.3M | $141.3M | $91.2M |
| Depreciation and amortization | $24.7M | $25.6M | $25.7M | $22.5M | $18.1M |
| Stock-based compensation | $80.3M | $61.5M | $48.2M | $60.5M | $56.8M |
| Capital expenditure | $29.9M | $11.7M | $22.3M | $26.5M | $28.6M |
| Free cash flow | $65.8M | -$25.7M | -$52.6M | $114.7M | $62.6M |
| Share repurchases | $0 | $16,000 | $217.1M | $883.4M | $1.2B |
Shares outstanding 33.0M · Free float 97.4%
Annual filing data through FY ended January 3, 2026; float as of July 11, 2026.